Simon says, city does Powerful family's interests helped Indianapolis thrive, but taxpayers have paid every step of the way

Billions Disappear The market downturn has clobbered state pension funds.

Losing A Lifeline? Traditionally a bastion of financial health, hospitals are feeling pain of a sick economy.

LOCKDOWN Nervous banks cut off some borrowers, tighten reins on others

Reshaping the Circle  Civic leaders envision transformation that could close city landmark to vehicles

Young, educated and living in Indy City shows up peers in luring, keeping key demographic

Mystery at Charter Homes King Park builder draws scrutiny

World-class challenge IUPUI faces tough decisions over aging sports facilities

$720 million stadium will open with a big operating deficit The hard work is only beginning for the city's Capital Improvement Board, the entity charged with operating the stadium.

Sports Corp's ownership of Pan Am Plaza a... BROKEN PLAY At most of Indiana's public firms, CEO pay hasn't fallen with stock. Did execs earn their keep?

Executive Pay - Measure of a Leader At most of Indiana's public firms, CEO pay hasn't fallen with stock. Did execs earn their keep?

Little cars, big demand High fuel prices take toll on resale values for trucks, SUVs

Small towns, big biz Hospitals mixed bag for rural economies

Healer or heretic J. Patrick Rooney shook up the insurance industry with health savings accounts. Now, he's taking aim at the way hospitals do business 'and they don't like it.

Few checks, big balance Outside of spotlight, township trustee taps taxpayers for millions; Drummer calls cash cushion prudent, but critic says it's 'absurd'

Seeking a piece of the pie Lilly's plan to outsource more work creates good news, bad news for city's life sciences sector

Charities face more empty chairs Group proposes pool of interim executives to fill expected shortage of top-level leaders

Polian's long and winding road Architect of Colts' success worked his way to the top

Shooting for smooth succession Companies must be prepared for CEO turnover, experts say

$2 Billion Challenge Lilly under gun to replace aging blockbuster Zyprexa.